Myopia And Presbyopia Treatment Market To Reach $45.4Bn By 2033

Myopia And Presbyopia Treatment Market Growth & Trends

The global myopia and presbyopia treatment market size is estimated to reach USD 45.4 billion by 2033, expanding at a CAGR of 9.7% from 2026 to 2033, according to a new report by Grand View Research, Inc. Growing research and development in the targeted disorders is expected to drive the market considerably over the forecast period. Moreover, the growing prevalence of myopia and high myopia is anticipated to fuel the market growth during the forecast period. Incidences of myopia in the developing countries of Asia Pacific, such as Japan, China, Singapore, and the Republic of Korea, are growing steeply in recent years.

The growing prevalence of myopia and presbyopia is an opportunity for industry players to introduce efficient treatment solutions. Among the developed nations, the U.S. is witnessing a significant boost in the incidence of myopia and presbyopia, especially in individuals over 42 years of age. The introduction of technologically advanced surgical options and high adoption rates in developed countries are expected to boost the market growth in the upcoming years.

Advanced diagnostic and surgical treatment solutions include LASIK, LASEK, and PRK. The integration of these techniques with artificial intelligence and robot-assisted surgical tools is expected to fuel the number of surgical procedures. The introduction of multifocal intraocular lenses and implantable contact lenses is expected to have a positive impact on the market growth.

 Request a free sample copy or view report summary: Myopia And Presbyopia Treatment Market Report

Myopia And Presbyopia Treatment Market Report Highlights

• By myopia treatment type, single prescription corrective lenses held a significant share in the market in 2025 owing to the progression of myopia with age, thus requiring frequent changes of corrective lenses

• Based on presbyopia treatment type, the progressive multifocal segment is expected to grow significantly over the forecast period owing to the wide acceptance due to aesthetic advantages

• Multifocal contact lenses for the correction of presbyopia held the second-largest share in 2025 largely due to the easy availability and effective outcomes

• Asia Pacific was the leading regional market in 2025 due to the rising demand for myopia and presbyopia contact lenses for vision correction

Myopia And Presbyopia Treatment Market Segmentation

Grand View Research has segmented the global myopia and presbyopia treatment market based on myopia treatment type, presbyopia treatment type, and region:

Myopia And Presbyopia Treatment Myopia Treatment Type Outlook (Revenue, USD Unit, 2021 - 2033)

• Corrective

  • Prescription lenses

    • Single

    • Bifocal

    • Trifocal

    • Others

  • Contact lenses

• Surgical

• Drugs

Myopia And Presbyopia Treatment Presbyopia Treatment Type Outlook (Revenue, USD Unit, 2021 - 2033)

• Prescription Lenses

  • Reading Glasses

  • Bifocals

  • Trifocals

  • Progressive Multifocals

  • Office Progressives

• Contact Lenses

  • Bifocal

  • Multifocal

  • Monovision

  • Modified Monovision

• Intraocular Lenses

• Refractive Surgery

Myopia And Presbyopia Treatment Region Outlook (Revenue, USD Unit, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Norway

  • Denmark

  • Sweden

• Asia Pacific

  • China

  • Japan

  • South Korea

  • Thailand

  • Australia

  • India

• Latin America

  • Brazil

  • Argentina

  • Colombia

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Myopia And Presbyopia Treatment Market

• Ziemer Ophthalmic Systems AG

• NIDEK CO., LTD.

• Johnson & Johnson Vision

• Essilor Ltd.

• Zeiss International

• ALCON VISION LLC

• Bausch & Lomb Incorporated

• Haag-Streit UK

• Topcon Corporation